Tramadol Hydrochloride — Veterinary Vademecum Drug Reference

Dosage & Administration Guidelines

Species	Route	Dose	Frequency	Duration & Clinical Notes
Dog	PO	2-5 mg/kg	q8-12h	Duration: As needed for pain Notes: Start at lower end for acute pain; may be used in combination with NSAIDs for multimodal analgesia.
Cat	PO	2-4 mg/kg	q12h	Duration: As needed for pain Notes: Cats may experience dysphoria at higher doses; monitor for behavioral changes.
Horse	IV	0.5-1 mg/kg	q8-12h	Duration: Short-term use Notes: Oral bioavailability is poor; parenteral administration is preferred.
Cattle	IV	1-2 mg/kg	q12h	Duration: Short-term use Notes: Extra-label use; not FDA-approved for food animals.
Rabbit	PO	5-10 mg/kg	q8-12h	Duration: As needed Notes: Limited data; use with caution.

Clinical Indications & Species Uses

General Indications

Mild to moderate pain management in various species

Dog (Canine)

Management of mild to moderate pain
Postoperative pain
Chronic pain (e.g., osteoarthritis)
Cancer pain

Cat (Feline)

Management of mild to moderate pain
Postoperative pain
Chronic pain (e.g., osteoarthritis)

Pharmacology & Mechanism of Action

Drug Class: Opioid Agonist (mu-opioid receptor agonist) with additional monoaminergic activity | Pharmacological Group: Analgesic, Opioid

Mechanism of Action: Tramadol is a centrally acting synthetic opioid analgesic. Its analgesic effect is mediated through two complementary mechanisms: (1) weak binding to mu-opioid receptors, and (2) inhibition of serotonin and norepinephrine reuptake in the central nervous system. The parent compound has low affinity for mu-opioid receptors, but its active metabolite, O-desmethyltramadol (M1), has significantly higher affinity and contributes substantially to the analgesic effect. The monoaminergic activity enhances descending inhibitory pain pathways, providing additional analgesia.

Pharmacodynamics: Tramadol produces analgesia by activating central opioid receptors and modulating monoaminergic pathways. It has a ceiling effect for respiratory depression and is less likely to cause significant sedation or euphoria compared to classical opioids. In veterinary species, the analgesic efficacy varies widely due to differences in metabolism and metabolite formation. It also has antitussive and local anesthetic properties at high doses.

⚡ Pharmacokinetics Summary

Absorption: Tramadol is well absorbed after oral administration in most species, but bioavailability is variable due to extensive first-pass metabolism. In dogs, oral bioavailability is approximately 65% (range 30-100%). In cats, oral bioavailability is around 90% (range 60-100%). In horses, oral bioavailability is low (approximately 3-10%) due to poor absorption and extensive metabolism.

Distribution: Tramadol is widely distributed throughout the body, with a volume of distribution of about 2-3 L/kg in dogs and cats. It crosses the blood-brain barrier and placenta. Protein binding is approximately 20% in dogs and 35% in cats.

Metabolism: Tramadol is extensively metabolized in the liver, primarily by cytochrome P450 enzymes. In dogs, the major metabolic pathway is O-demethylation to M1 (active) and N-demethylation to inactive metabolites. In cats, the metabolism is less efficient, leading to higher plasma concentrations of the parent drug. In horses, metabolism is extensive, with the active metabolite M1 being produced in very low amounts.

Excretion: Tramadol and its metabolites are primarily excreted via the kidneys. In dogs, approximately 90% of the dose is excreted in urine, with about 30% as unchanged drug. In cats, renal excretion is also the primary route. In horses, fecal excretion may be significant due to poor absorption.

Half-Life: Dog: 1.5-2 hours (parent drug), 1.7-2.5 hours (M1); Cat: 2-4 hours (parent drug), 4-6 hours (M1); Horse: 1.5-2 hours (parent drug); Cattle: 1-2 hours (parent drug)

Bioavailability: Dog: ~65% (oral); Cat: ~90% (oral); Horse: ~3-10% (oral)

Protein Binding: Dog: ~20%; Cat: ~35%; Horse: ~20%

Available Formulations & Strengths

Oral Tablet 50 mg (PO)

Oral Tablet (extended-release) 100 mg, 200 mg (PO)

Injectable Solution 50 mg/mL (IV, IM, SC)

Oral Liquid 10 mg/mL (PO)

Contraindications & Clinical Warnings

Contraindications:

Hypersensitivity to tramadol or other opioids
Concurrent use of MAO inhibitors (within 14 days)
Severe respiratory depression
Acute intoxication with alcohol, hypnotics, or other CNS depressants
Severe hepatic or renal impairment (use with caution)
In animals with seizure disorders (may lower seizure threshold)

Warnings & Clinical Precautions:

Use with caution in animals with head trauma or increased intracranial pressure
Use with caution in animals with hypothyroidism, Addison's disease, or prostatic hypertrophy
May cause sedation and ataxia; monitor for CNS effects
In cats, may cause mydriasis and behavioral changes
In horses, may cause excitation and colic
Do not crush or chew extended-release tablets
Use with caution in animals with renal or hepatic impairment; dose adjustment may be necessary
Tramadol may interact with serotonergic drugs (e.g., SSRIs, TCAs) leading to serotonin syndrome
In food animals, observe withdrawal times; extra-label use requires veterinary oversight

Adverse Effects & Reactions

Common:

Sedation
Dysphoria (especially in cats)
Gastrointestinal upset (nausea, vomiting)
Constipation
Mydriasis (cats)

Serious / Severe:

Respiratory depression
Seizures (especially at high doses or in predisposed animals)
Serotonin syndrome (when combined with serotonergic drugs)
Hypotension
Bradycardia

Rare:

Allergic reactions
Hepatic enzyme elevations
Urinary retention

Key Drug Interactions

Interacting Drug / Class	Clinical Effect & Mechanism	Severity
MAO inhibitors (e.g., selegiline)	Increased risk of serotonin syndrome and CNS excitation	High
SSRIs (e.g., fluoxetine) and SNRIs (e.g., duloxetine)	Increased risk of serotonin syndrome	High
Tricyclic antidepressants (e.g., amitriptyline)	Increased risk of seizures and serotonin syndrome	High
Other CNS depressants (e.g., benzodiazepines, barbiturates)	Additive sedation and respiratory depression	Moderate
Tramadol may reduce the seizure threshold; use with caution with drugs that lower seizure threshold (e.g., phenothiazines)	Increased risk of seizures	Moderate
Warfarin	Potential increased risk of bleeding (reports in humans)	Moderate

Overdose & Toxicity Management

Signs of Toxicity:

Respiratory depression
CNS depression (lethargy, coma)
Seizures
Miosis or mydriasis
Hypotension
Bradycardia
Cardiac arrest (in severe cases)

Emergency Treatment Protocol: Treatment is primarily supportive. Maintain airway and assist ventilation if needed. Administer oxygen. Monitor vital signs. For respiratory depression, administer naloxone (opioid antagonist) at a dose of 0.01-0.04 mg/kg IV, repeated as needed. For seizures, use diazepam or other anticonvulsants. In cases of serotonin syndrome, use cyproheptadine (1.1 mg/kg in dogs, 2-4 mg/cat) and supportive care. Gastrointestinal decontamination (e.g., activated charcoal) may be considered if ingestion was recent. Hospitalization and intensive monitoring are recommended.

Food Animal Withdrawal Times

Tramadol is not approved for use in food animals in the US. Extra-label use requires a veterinary prescription and extended withdrawal times must be considered. No official withdrawal times are established; a conservative withdrawal period of at least 7 days for meat and 5 days for milk is often recommended, but this is not FDA-approved. Consult FARAD (Food Animal Residue Avoidance Databank) for current recommendations.

Storage, Handling & Regulatory Information

Storage Temperature: Store at controlled room temperature (20-25°C, excursions permitted to 15-30°C)

Handling & Special Conditions: Protect from moisture. Keep in tight container. Store away from heat and direct sunlight.

Dispensing Status: Prescription Required (Rx Only)

Approval Status: Tramadol is not FDA-approved for veterinary use in the US, but it is commonly used extra-label. It is approved for human use.

Extra-Label (Off-Label) Use: In the US, extra-label use of tramadol in animals is permitted under AMDUCA (Animal Medicinal Drug Use Clarification Act) for non-food animals. For food animals, extra-label use is prohibited unless a valid veterinarian-client-patient relationship exists and there is no approved alternative. Withdrawal times must be extended and monitored.

Clinical Pearls & Practice Notes

💡 Clinical Insights: Tramadol is a useful analgesic for mild to moderate pain in dogs and cats, but its efficacy is variable due to species differences in metabolism. In dogs, the active metabolite M1 is produced in sufficient quantities, but in cats, the parent drug is more prominent, and the analgesic effect may be less predictable. In horses, oral bioavailability is very low, so parenteral administration is preferred. Tramadol is often used as part of a multimodal analgesic protocol, especially with NSAIDs. It is important to monitor for adverse effects, particularly in cats, where dysphoria and mydriasis can occur. Due to its opioid activity, tramadol is a controlled substance in some jurisdictions, and proper storage and record-keeping are required. In food animals, extra-label use is discouraged due to lack of withdrawal data. Always use the lowest effective dose for the shortest duration.

References & Literature

📚 Plumb's Veterinary Drug Handbook
📚 Papich Veterinary Pharmacology and Therapeutics
📚 Compendium of Veterinary Products (CVP)